Technique uses 3-D weaving to grow a living hip replacement
With a goal of treating worn, arthritic hips without extensive surgery to replace them, scientists have programmed stem cells to grow new cartilage on a 3-D template shaped like the ball of a hip joint. What’s more, using gene therapy, they have activated the new cartilage to release anti-inflammatory molecules to fend off a return of arthritis.
The technique, demonstrated in a collaborative effort between Washington University School of Medicine in St. Louis and Cytex Therapeutics Inc. in Durham, N.C., is described July 18 in Proceedings of the National Academy of Sciences.
The discovery one day may provide an alternative to hip-replacement surgery, particularly in younger patients. Doctors are reluctant to perform such operations in patients under age 50 because prosthetic joints typically last for less than 20 years. A second joint-replacement surgery to remove a worn prosthetic can destroy bone and put patients at risk for infection.
“Replacing a failed prosthetic joint is a difficult surgery,” said Farshid Guilak, PhD, a professor of orthopedic surgery at Washington University. “We’ve developed a way to resurface an arthritic joint using a patient’s own stem cells to grow new cartilage, combined with gene therapy to release anti-inflammatory molecules to keep arthritis at bay. Our hope is to prevent, or at least delay, a standard metal and plastic prosthetic joint replacement.”
The technique uses a 3-D, biodegradable synthetic scaffold that Guilak and his team developed. The scaffold, molded into the precise shape of a patient’s joint, is covered with cartilage made from the patient’s own stem cells taken from fat beneath the skin. The scaffold then can be implanted onto the surface of an arthritic hip, for example. Resurfacing the hip joint with “living” tissue is designed to ease arthritis pain, and delay or even eliminate the need for joint-replacement surgery in some patients.
Additionally, by inserting a gene into the newly grown cartilage and activating it with a drug, the gene can orchestrate the release of anti-inflammatory molecules to fight a return of arthritis, which usually is what triggers such joint problems in the first place.
“When there is inflammation, we can give a patient a simple drug, which activates the gene we’ve implanted, to lower inflammation in the joint,” said Guilak, also a professor of developmental biology and of biomedical engineering. “We can stop giving the drug at any time, which turns off the gene.”
That gene therapy is important, he explained, because when levels of inflammatory molecules rise in a joint, the cartilage is destroyed and pain increases. By adding gene therapy to the stem cell and scaffold technique, Guilak and his colleagues believe it will be possible to coax patients’ joints to fend off arthritis and function better for a longer time.
The 3-D scaffold is built using a weaving pattern that gives the device the structure and properties of normal cartilage. Franklin Moutos, PhD, vice president of technology development at Cytex, explained that the unique structure is the result of approximately 600 biodegradable fiber bundles woven together to create a high-performance fabric that can function like normal cartilage.
“As evidence of this, the woven implants are strong enough to withstand loads up to 10 times a patient’s body weight, which is typically what our joints must bear when we exercise,” Moutos said.
Currently, there are about 30 million Americans who have diagnoses of osteoarthritis, and data suggest that the incidence of osteoarthritis is on the rise. That number includes many younger patients — ages 40 to 65 — who have limited treatment options because conservative approaches haven’t worked and they are not yet candidates for total joint replacement because of their ages.
Bradley Estes, PhD, vice president of research and development at Cytex, noted, “We envision in the future that this population of younger patients may be ideal candidates for this type of biological joint replacement.”
Guilak, who also is the director of research at Shriners Hospitals for Children — St. Louis, and co-director of the Washington University Center of Regenerative Medicine, has been collaborating with Cytex on this research. The scientists have tested various aspects of the tissue engineering in cell culture, and some customized implants already are being tested in laboratory animals. He said if all goes well, such devices could be ready for safety testing in humans in three to five years.
The Latest on: Stem cells to grow new cartilage
via Google News
The Latest on: Stem cells to grow new cartilage
- Stem cell therapy helped Owen Franks but there's still plenty to proveon October 10, 2019 at 6:50 am
where cells and tissues can be engineered to grow healthy, functional organs to replace diseased ones; new genes can be introduced into the body to combat disease; and adult stem cells can generate ...
- Dr. John Kennedy: Trends in platelet-rich plasma, stem cells for sports medicineon October 3, 2019 at 9:08 am
John Kennedy, MD, is chief of the division of foot and ankle surgery and professor in the department of orthopedic surgery at NYU Langone in New York City ... concentrated and provides stem cells, ...
- Stem Cellson September 29, 2019 at 5:00 pm
are hybrid cartilage/bone cells, which are stimulated to participate in repair by “messenger” cells. (Image by Stephanie T. Kuwahara and Francesca Mariani/USC Stem Cell) According to a new USC study ...
- Stem Cell Cartilage Regeneration Market By Current Industry Status,Growth Opportunities, Top Key Players, Target Audience And Forecast To 2025on August 27, 2019 at 1:35 am
Aug 27, 2019 (Garth Media via COMTEX) -- In this report, the global Stem Cell Cartilage Regeneration market is valued at USD XX million in 2017 and is... MarketWatch site logo Latest ...
- Drops of cartilage tissue could be injected into the knees to ease creaky joints avoiding replacement surgery in new treatmenton August 6, 2019 at 4:43 am
Left untreated, defects can grow larger, leading to arthritis ... With microfracture, the stem cells form new cartilage, but it is unstructured and less hard-wearing than normal cartilage and does not ...
- Stem cells grow cartilage to fix hipson July 24, 2019 at 5:00 pm
Scientists are developing a way to treat arthritic hips without extensive surgery to replace them. They’ve programmed stem cells to grow new cartilage on a 3D template shaped like the ball of a hip ...
- Grow fresh cartilage from adult stem cellson June 6, 2019 at 5:00 pm
U. PENNSYLVANIA (US) — Bioengineers are a step closer to growing new cartilage from a patient’s own stem cells. Cartilage injuries are difficult to repair. Current surgical options generally involve ...
- Stem cell treatments for arthritic knees are unproven, expensive and potentially dangerouson February 5, 2019 at 3:57 am
according to a report in The New York Times that should cause patients concern. More important is that they should investigate stem cell treatments, for conditions such as cartilage injuries to their ...
- Study identifies stem cell that gives rise to new bone, cartilage in humanson September 20, 2018 at 8:14 am
The discovery of a skeletal stem cell in mice sets the stage for new methods to grow cartilage and bone for use in medical therapies.
- Study identifies stem cell that gives rise to new bone and cartilage in humanson September 20, 2018 at 8:03 am
"Now we can begin to understand why human bone is denser than that of mice, or why human bones grow to be so ... and treat damaged cartilage—could include the injection of a skeletal stem cell ...
via Bing News